Jiangsu Hualv Biological Technology Co.Ltd. Net Asset Quality Index
Jiangsu Hualv Biological Technology Co.Ltd. net asset quality index. Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Net Asset Quality Index of 64.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.60 Billion minus total liabilities of CN¥919.95 Million yields net assets of CN¥1.68 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Jiangsu Hualv Biological Technology Co.L for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Net asset quality index of Jiangsu Hualv Biological Technology Co.Ltd. from 2019 to 2025. This chart shows how Jiangsu Hualv Biological Technology Co.Ltd.'s Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 64.6%, representing net assets of CN¥1.68 Billion against total assets of CN¥2.60 Billion CNY. Check Jiangsu Hualv Biological Technology Co.L tangible equity quality to evaluate the tangible quality of the company's equity base.
Jiangsu Hualv Biological Technology Co.Ltd. Net Asset Quality Index by Year (2019–2025)
Jiangsu Hualv Biological Technology Co.Ltd. net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Jiangsu Hualv Biological Technology Co.Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Jiangsu Hualv Biological Technology Co.L worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.7% | CN¥1.67 Billion | CN¥2.47 Billion | CN¥797.40 Million | ▲ +1.8 pp |
| 2024 | 65.9% | CN¥1.52 Billion | CN¥2.31 Billion | CN¥786.12 Million | ▼ -8.1 pp |
| 2023 | 74.0% | CN¥1.57 Billion | CN¥2.12 Billion | CN¥551.03 Million | ▼ -2.9 pp |
| 2022 | 76.9% | CN¥1.52 Billion | CN¥1.98 Billion | CN¥457.83 Million | ▲ +0.3 pp |
| 2021 | 76.6% | CN¥1.44 Billion | CN¥1.88 Billion | CN¥438.92 Million | ▲ +3.5 pp |
| 2020 | 73.1% | CN¥851.05 Million | CN¥1.16 Billion | CN¥313.67 Million | ▲ +0.6 pp |
| 2019 | 72.4% | CN¥737.21 Million | CN¥1.02 Billion | CN¥280.52 Million | — |